Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kyriazi Theo Melas currently holds 15,350 shares of VALEANT PHARMACEUTICALS INTERNATIONAL (VRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kyriazi Theo Melas has been a net buyer of VRX stock. They have purchased $641.7K and sold $0 worth of shares.
Kyriazi Theo Melas's most recent insider trade was on Feb 16, 2023, when they sold 8,750 shares at $0.00 per share.
Kyriazi Theo Melas serves as Executive at VALEANT PHARMACEUTICALS INTERNATIONAL (VRX). They have executed 64 insider transactions totaling $641.7K over their tenure at the company.
Kyriazi Theo Melas holds the position of Executive at VALEANT PHARMACEUTICALS INTERNATIONAL, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Kyriazi Theo Melas has shown a buying trading pattern, with $641.7K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Kyriazi Theo Melas was on May 30, 2013, when they sold $614.1K worth of VRX shares. This transaction involved 6,762 shares at $90.81 per share.
Kyriazi Theo Melas currently owns 15,350 shares of VALEANT PHARMACEUTICALS INTERNATIONAL (VRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kyriazi Theo Melas's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kyriazi Theo Melas has 64 Form 4 filings on record as an insider at VALEANT PHARMACEUTICALS INTERNATIONAL.
Set alerts for Kyriazi Theo Melas and 40,000+ other insiders.